My 2 best ASX growth shares to buy in November

Growth continues to catch the market's attention.

| More on:
A smiling travel agent sitting at her desk working for Corporate Travel Management

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The intrigue of ASX growth shares enthrals many investors. Often, stocks in this category catch headlines and see their shares bid up to high prices.

Qualifying these companies for 'growth' is the growth in their historical and future sales or profits.

Two companies stand out in the growth domain with projected growth in profits and share prices over the coming years. These are Neuren Pharmaceuticals Ltd (ASX: NEU) and Flight Centre Travel Group Ltd (ASX: FLT).

In my view – and the view of several experts – these names stand out as potential winners this month for those seeking exposure to ASX growth shares. Let's take a closer look.

ASX growth shares in favour

First on the list of ASX growth shares is Neuren Pharmaceuticals. It specialises in developing treatments for neurological disorders, and its innovative pipeline has captured significant attention from investors.

The company's NNZ-2591 candidate, aimed at treating Phelan-McDermid syndrome, has been the focus of several brokers.

Bell Potter believes this product could be the accelerant to the fire of Neuren's earnings growth and maintains a buy rating with a $25 price target.

This implies a potential 101% upside from its closing price on Thursday.

Neuren management also anticipates receiving up to $150 million in milestone payments by the first quarter of 2025, which is more than 8.5% of its current market value.

The cash injection positions Neuren to fund its pipeline, which includes Phase 3 trials – the final stages before drug commercialisation.

According to CommSec, consensus expects Neuren to earn 58 cents per share in 2024. Estimates show this could stretch up to 88 cents per share, or 52% growth the following year. In my view, this qualifies Neuren as an ASX growth share.

Why Flight Centre is a turnaround opportunity

Flight Centre is the second of today's ASX growth shares in question. It has had a turbulent few years, but it's emerging as a leaner, more efficient business.

The recent sell-off, driven by a softer first-quarter update, hasn't spooked everyone. Au contraire, it has excited some experts.

Fund manager L1 Capital sees Flight Centre as a turnaround story, citing its improved operational structure and ambitious profitability targets.

The company "has also shifted the mix towards more luxury travel and independent store networks".

According to my colleague Tristan, the company aims for a 2% profit margin over the medium term, which, if achieved, could translate into a 50% profit boost from 2024 levels.

According to CommSec, the consensus rates the stock a buy and sees earnings growth of approximately 17% per year for the next two years.

Macquarie also rates the stock a buy with a $23.34 price target, suggesting a potential 37% upside from Flight Centre's closing price on Thursday.

Why these ASX growth shares could deliver

These two ASX growth shares might be candidates on your list after reading what the experts have said on their prospects.

Remember that growth shares do have the potential for higher earnings growth, but there are also valuation factors to consider.

Flight Centre is down 11% in the past year, whereas Neuren is down 16%.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
Growth Shares

Top Australian shares to buy right now with $5,000 

Analysts see potential for these shares to deliver big returns.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Growth Shares

3 ASX 200 growth shares that could supercharge your portfolio returns in 2025

Analysts think these growth shares could generate big returns for investors next year.

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

2 fantastic ASX growth stocks to buy and hold for 10 years

Analysts have good things to say about these growing companies.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Growth Shares

3 ASX 200 growth shares to buy for 20% to 30% returns

Analysts are tipping these shares to rise strongly from current levels.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Growth Shares

Invest $10,000 into these Australian shares in December

Analysts think these shares could generate big returns for investors.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Growth Shares

2 of the best ASX growth shares money can buy

Bell Potter rates these growth shares very highly. But why?

Read more »

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Growth Shares

Buy these ASX growth shares for 16% to 25% returns

Analysts are saying good things about these buy-rated shares.

Read more »

two children squat down in the dirt with gardening tools and a watering can wearing denim overalls and smiling very sweetly.
Growth Shares

How to maximise $10,000 by investing in 2 ASX growth shares

Here are my best growth ideas on the ASX right now.

Read more »